LifeStance Health (LFST) Depreciation & Amortization (CF) (2020 - 2026)

LifeStance Health has disclosed Depreciation & Amortization (CF) across 7 years of filings, most recently posting $13.3 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 3.18% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $54.3 million (down 12.6% YoY), while the FY2025 annual figure was $54.8 million, down 22.83% from the prior year.
• Depreciation & Amortization (CF) fell to $13.3 million in Q1 2026, from $13.4 million in the prior quarter.
• Over the last five years, Depreciation & Amortization (CF) for LFST reached as high as $22.6 million in Q1 2024 and fell as low as $13.3 million in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $16.7 million (2022), against an average of $17.0 million.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 31.07% — and 2025, when it slumped 39.04%.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $18.9 million in 2022, then rose by 17.63% to $22.2 million in 2023, then tumbled by 33.96% to $14.7 million in 2024, then dropped by 8.43% to $13.4 million in 2025, then retreated by 0.86% to $13.3 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $13.3 million, $13.4 million, and $13.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.